1 alpha,25-Dihydroxyvitamin D3 increases transforming growth factor and transforming growth factor receptor type I and II synthesis in human bone cells.

Wu, Y

1 alpha,25-Dihydroxyvitamin D3 increases transforming growth factor and transforming growth factor receptor type I and II synthesis in human bone cells. [electronic resource] - Biochemical and biophysical research communications Oct 1997 - 734-9 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0006-291X

10.1006/bbrc.1997.7544 doi


Activin Receptors, Type I
Antibodies--pharmacology
Calcitriol--antagonists & inhibitors
Cell Line
Cell-Free System
Dose-Response Relationship, Drug
Fetus
Growth Inhibitors--antagonists & inhibitors
Growth Substances--metabolism
Humans
Osteoblasts--cytology
Protein Serine-Threonine Kinases--biosynthesis
RNA, Messenger--drug effects
Receptor, Transforming Growth Factor-beta Type I
Receptor, Transforming Growth Factor-beta Type II
Receptors, Transforming Growth Factor beta--biosynthesis
Transcription, Genetic--drug effects
Transforming Growth Factor beta--biosynthesis